查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462972

流感诊断市场,占有率,市场规模,趋势,行业分析报告:依产品,测试类型,最终用途,地区,细分市场预测2024-2032 年

Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球流感诊断市场预计将达到 14.6 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于全世界对流感的认识和关注不断增加，流感诊断市场正在成长。流感具有高度传染性，可导致严重疾病，因此早期发现和管理变得越来越重要。每年发生的流行病凸显了准确诊断的必要性，以减少对个人和医疗保健系统的影响。此外，流感大流行的经济和社会影响增加了对有效诊断解决方案的需求。COVID-19 大流行进一步凸显了呼吸道感染的风险，并刺激了对诊断测试的需求。快速现场检测和分子检测等先进技术可提供更快、更准确的结果，从而促进市场成长。

老年人和慢性病患者特别容易出现流感併发症，需要及时、准确的诊断。随着世界人口结构转向人口老化和慢性病的增加，对流感诊断解决方案的需求不断增加。老年人的免疫系统通常较弱，这使他们患流感的风险增加。同样，患有慢性病的人也更容易受到伤害。医疗保健提供者正在优先考虑对这一群体进行早期流感检测，以预防併发症。此外，由于人口老化和慢性病，流感对医疗保健系统带来的负担不断增加，增加了对有效诊断工具的需求。

远端监控和远距医疗解决方案使医疗保健提供者能够远端诊断流感，从而最大限度地减少医院就诊的需要。患者可以在家中咨询医疗保健专业人员，减少接触传染病的机会。远距医疗平台整合了远端体温监测设备和数位温度计等诊断工具，用于即时症状评估。穿戴式科技持续监测生命征象，可以帮助诊断流感。此外，这些解决方案还优化了资源分配并降低了医疗成本。透过促进及时诊断和治疗来增强患者治疗效果和疾病管理。

由于多重检测的日益普及，流感诊断市场的需求也激增。多重检测可以在一次测试中同时检测多种病原体，包括流感病毒和其他呼吸道病原体。多重检测可提供更快的周转时间、减少样本量并提高诊断准确性。多重检测简化了工作流程，改善了病患管理策略，并透过最大限度地减少多次检测的需要来节省资源。随着医疗保健系统专注于增强呼吸道感染的诊断能力，对多重检测的需求预计将继续增加并推动市场成长。

流感诊断市场报告亮点

2023年，由于医疗环境中的广泛采用、流感季节的高需求、政府措施和疫情对策，检测试剂盒和试剂产业占销售额的很大一部分。

2023年，RIDT领域由于见效快、成本效益高且用途广泛，占据了很大的销售占有率。

到 2023 年，由于病患量大、医疗保健服务全面，并且可以获得专业设备，医院部门将占据重要的销售占有率。

2023年，北美地区凭藉先进的医疗基础设施、高额医疗支出以及主要市场参与者的强大影响力，在全球市场中占据主导地位。

该市场由 Abbott Laboratories、Becton、Dickinson and Company (BD)、bioMerieux SA、F. Hoffmann-La Roche Ltd.、Luminex Corporation、Meridian Bioscience, Inc.、Quidel Corporation 和 Thermo Fisher Scientific Inc. 等全球公司主导由于有实力雄厚的公司进入市场，竞争非常激烈。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球流感诊断市场洞察

  • 流感诊断市场－最终用途概况
  • 流感诊断市场动态
    • 驱动因素和机遇
      • 流感发生率上升预计将增加产品需求
      • 越来越多地采用现场检测预计将推动流感诊断市场的成长。
    • 限制因素和课题
      • 监管课题和合规要求可能会阻碍市场成长
  • PESTEL 分析
  • 流感诊断市场最终用途趋势
  • 价值链分析
  • COVID-19 影响分析

第五章依测试类型划分的全球市场

  • 主要发现
  • 介绍
  • RIDT
  • 细胞培养
  • 逆转录聚合酶链反应
  • 其他

第六章依产品划分的世界市场

  • 主要发现
  • 介绍
  • 机器
  • 检测试剂盒和试剂
  • 其他

第七章依最终用途划分的全球市场

  • 主要发现
  • 介绍
  • 医院
  • 诊断实验室
  • 其他

第八章依地区划分的世界市场

  • 主要发现
  • 介绍
    • 2019-2032 年流感诊断市场评估（依地区）
  • 流感诊断市场 - 北美
    • 北美：流感诊断市场，依测试类型，2019-2032
    • 北美：流感诊断市场，依最终用途，2019-2032 年
    • 北美：流感诊断市场（依产品），2019-2032 年
    • 流感诊断市场—美国
    • 流感诊断市场－加拿大
  • 流感诊断市场—欧洲
    • 欧洲：流感诊断市场，依检验类型，2019-2032
    • 欧洲：流感诊断市场，依最终用途，2019-2032 年
    • 欧洲：流感诊断市场（依产品），2019-2032
    • 流感诊断市场—英国
    • 流感诊断市场—法国
    • 流感诊断市场—德国
    • 流感诊断市场—义大利
    • 流感诊断市场—西班牙
    • 流感诊断市场—荷兰
    • 流感诊断市场—俄罗斯
  • 流感诊断市场－亚太地区
    • 亚太地区：流感诊断市场（依检验类型），2019-2032 年
    • 亚太地区：流感诊断市场（依最终用途），2019-2032 年
    • 亚太地区：流感诊断市场（依产品），2019-2032 年
    • 流感诊断市场—中国
    • 流感诊断市场—印度
    • 流感诊断市场 - 马来西亚
    • 流感诊断市场—日本
    • 流感诊断市场—印度尼西亚
    • 流感诊断市场—韩国
  • 流感诊断市场—中东和非洲
    • 中东和非洲：流感诊断市场（依测试类型），2019-2032 年
    • 中东和非洲：流感诊断市场（以最终用途），2019-2032 年
    • 中东和非洲：流感诊断市场（依产品），2019-2032 年
    • 流感诊断市场－沙乌地阿拉伯
    • 流感诊断市场－阿联酋
    • 流感诊断市场—以色列
    • 流感诊断市场—南非
  • 流感诊断市场 - 拉丁美洲
    • 拉丁美洲：流感诊断市场（依测试类型），2019-2032 年
    • 拉丁美洲：流感诊断市场，依最终用途，2019-2032 年
    • 拉丁美洲：流感诊断市场（依产品），2019-2032 年
    • 流感诊断市场—墨西哥
    • 流感诊断市场—巴西
    • 流感诊断市场—阿根廷

第9章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/出版物

第十章公司简介

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CorisBioConcept
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Sekisui Diagnostics
  • Thermo Fisher Scientific Inc.
Product Code: PM4663

The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2032, according to a new study by Polaris Market Research. The report "Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The influenza diagnostics market is growing due to heightened awareness and concerns about influenza globally. With influenza's contagious nature and potential for severe illness, there's increasing emphasis on early detection and management. Annual outbreaks underscore the necessity for accurate diagnosis to mitigate its impact on individuals and healthcare systems. Additionally, the economic and societal repercussions of influenza outbreaks drive demand for effective diagnostic solutions. The COVID-19 pandemic has further highlighted respiratory infection risks, fueling demand for diagnostic testing. Advanced technologies like rapid point-of-care tests and molecular assays offer faster, more accurate results, contributing to market growth.

Elderly individuals and those with chronic diseases are especially susceptible to severe influenza complications, necessitating timely and accurate diagnostics. With global demographics shifting towards aging populations and rising chronic conditions, demand for influenza diagnostic solutions is heightened. Elderly individuals often have compromised immune systems, elevating their influenza risk. Similarly, those with chronic ailments face increased vulnerability. Healthcare providers prioritize early influenza detection in these groups to prevent complications. Additionally, the burden of influenza on healthcare systems intensifies with aging populations and chronic conditions, driving the need for effective diagnostic tools.

Remote monitoring and telemedicine solutions enable healthcare providers to diagnose influenza remotely, minimizing the need for in-person visits. Patients can consult healthcare professionals from home, reducing exposure to infectious diseases. Telemedicine platforms integrate diagnostic tools like remote temperature monitoring devices and digital thermometers for real-time symptom assessment. Wearable technology continuously monitors vital signs, aiding influenza diagnosis. Additionally, these solutions optimize resource allocation and reduce healthcare costs. By facilitating timely diagnosis and treatment, they enhance patient outcomes and disease management.

The influenza diagnostics market is also witnessing a surge in demand driven by the growing adoption of multiplex assays. These assays enable simultaneous detection of various pathogens, including influenza viruses and other respiratory pathogens, in a single test. They offer faster turnaround times, reduced sample volumes, and enhanced diagnostic accuracy. Multiplex assays streamline workflows, improve patient management strategies, and conserve resources by minimizing the need for multiple tests. As healthcare systems focus on enhancing their capacity for diagnosing respiratory infections, the demand for multiplex assays is expected to continue rising, fueling market growth.

Influenza Diagnostics Market Report Highlights

In 2023, the test kit and reagents segment held a significant revenue share owing to wide adoption in healthcare settings, high demand during flu seasons, and government initiatives and pandemic preparedness.

In 2023, the RIDT segment held a significant revenue share owing to rapid results, cost-effectiveness, and established usage.

In 2023, the hospital's segment held a significant revenue share owing to high patient footfall, comprehensive healthcare services, and access to specialized equipment.

In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare spending, and the strong presence of key market players.

The market is highly competitive owing to the existence of market players with a global presence, including Abbott Laboratories, Becton, Dickinson and Company (BD), bioMerieux SA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Influenza Diagnostics market report based on product, test type, end use, and region:

Influenza Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Test Kit and Reagents
  • Others

Influenza Diagnostics, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • RIDT
  • Cell Culture
  • RT-PCR
  • Others

Influenza Diagnostics, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Others

Influenza Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Diagnostics Market Insights

  • 4.1. Influenza Diagnostics Market - End Use Snapshot
  • 4.2. Influenza Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of influenza is projected to spur product demand
      • 4.2.1.2. Increasing adoption of point-of-care testing is expected to drive influenza diagnostics market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges and compliance requirements are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • 5.3. RIDT
    • 5.3.1. Global Influenza Diagnostics Market, by RIDT, by Region, 2019-2032 (USD Billion)
  • 5.4. Cell Culture
    • 5.4.1. Global Influenza Diagnostics Market, by Cell Culture, by Region, 2019-2032 (USD Billion)
  • 5.5. RT-PCR
    • 5.5.1. Global Influenza Diagnostics Market, by RT-PCR, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Influenza Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Influenza Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Test Kit and Reagents
    • 6.4.1. Global Influenza Diagnostics Market, by Test Kit and Reagents, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Influenza Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Influenza Diagnostics Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Influenza Diagnostics Market, by Diagnostic Laboratories, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Influenza Diagnostics Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Influenza Diagnostics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Influenza Diagnostics Market - North America
    • 8.3.1. North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Influenza Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Influenza Diagnostics Market - Canada
      • 8.3.5.1. Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Influenza Diagnostics Market - Europe
    • 8.4.1. Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Influenza Diagnostics Market - UK
      • 8.4.4.1. UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Influenza Diagnostics Market - France
      • 8.4.5.1. France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Influenza Diagnostics Market - Germany
      • 8.4.6.1. Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Influenza Diagnostics Market - Italy
      • 8.4.7.1. Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Influenza Diagnostics Market - Spain
      • 8.4.8.1. Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Influenza Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Influenza Diagnostics Market - Russia
      • 8.4.10.1. Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Influenza Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Influenza Diagnostics Market - China
      • 8.5.4.1. China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Influenza Diagnostics Market - India
      • 8.5.5.1. India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Influenza Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Influenza Diagnostics Market - Japan
      • 8.5.7.1. Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Influenza Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Influenza Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Influenza Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Influenza Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Influenza Diagnostics Market - UAE
      • 8.6.5.1. UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Influenza Diagnostics Market - Israel
      • 8.6.6.1. Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Influenza Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Influenza Diagnostics Market - Latin America
    • 8.7.1. Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Influenza Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Influenza Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Influenza Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CorisBioConcept
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. DiaSorin S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GenMark Diagnostics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hologic, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Luminex Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Meridian Bioscience, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Quidel Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. SA Scientific, Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sekisui Diagnostics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Thermo Fisher Scientific Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 2 Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 6 North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 18 UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 21 France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 42 China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 45 India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Influenza Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Influenza Diagnostics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Test Type
  • Figure 9. Global Influenza Diagnostics Market, by Test Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Influenza Diagnostics Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 12. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Influenza Diagnostics Market